The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the proposed Settlement in the Spectrum Pharmaceuticals, Inc. Litigation: SPECTRUM PHARAMCEUTICALS, INC., et al.

Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired iRobot Corporation (NASDAQ: ...

Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected].

"No investigation is perfect. There's always going to be things that you can question, that you can attack," Vice Chancellor ...

Robbins Geller files suit against Rocket Pharma over undisclosed trial risks tied to RP-A501. Lead plaintiff deadline: August ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

Sarepta is facing a shareholder lawsuit over ELEVIDYS-related deaths. Robbins LLP cites safety risks and stock losses.

SAN DIEGO, July 07, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Sarepta Therapeutics, Inc ...

Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Fortrea Holdings, Inc.

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc ...